Narrated Voices of African American Women in Academe

This study was conducted to investigate the academic experiences of selected African American women faculty and administrators employed by two-year and four-year predominantly white institutions. The sample selection was purposeful, and three faculty members and two administrators agreed to participate. Each participant was interviewed on five separate occasions using an open-ended interview guide. Data analysis followed the standard inductive coding procedures articulated by Y. Lincoln and E. Guba (1985), and the constant comparative method (A. Strauss and J. Corbin, 1990) was used to generate theory in the study. The narratives of the participants provide insight into the academic experiences of other black female faculty and administrators, but should not be interpreted as representing the experiences of all black women in academia. Race appears to be the environmental landscape of the academic experiences of these women. The influence of social class is not as easily discernable as that of race, but it was present and contributed to the shaping of their academic experiences. Gender was an issue, especially since some of these women were aware that they had been hired to add minority and female participation to an academic department and that they represented two-for-one for department administrators. Race, class, and gender operated independently and collectively to shape and influence the academic experiences of the women in this study

Concordance Between Electronic Health Record Data and Medicare Part D Claims Data for Oral Anticancer Drug Use

Real-world evidence from electronic health records (EHRs) and claims data are being evaluated for use in regulatory decision-making.1,2 The objective of our study was to determine the concordance between EHR and Medicare Part D (MPD) claims data for the receipt of oral anticancer agents, a rapidly growing treatment option for cancer

Extraction of coherent structures in a rotating turbulent flow experiment

The discrete wavelet packet transform (DWPT) and discrete wavelet transform (DWT) are used to extract and study the dynamics of coherent structures in a turbulent rotating fluid. Three-dimensional (3D) turbulence is generated by strong pumping through tubes at the bottom of a rotating tank (48.4 cm high, 39.4 cm diameter). This flow evolves toward two-dimensional (2D) turbulence with increasing height in the tank. Particle Image Velocimetry (PIV) measurements on the quasi-2D flow reveal many long-lived coherent vortices with a wide range of sizes. The vorticity fields exhibit vortex birth, merger, scattering, and destruction. We separate the flow into a low-entropy ``coherent'' and a high-entropy ``incoherent'' component by thresholding the coefficients of the DWPT and DWT of the vorticity fields. Similar thresholdings using the Fourier transform and JPEG compression together with the Okubo-Weiss criterion are also tested for comparison. We find that the DWPT and DWT yield similar results and are much more efficient at representing the total flow than a Fourier-based method. Only about 3% of the large-amplitude coefficients of the DWPT and DWT are necessary to represent the coherent component and preserve the vorticity probability density function, transport properties, and spatial and temporal correlations. The remaining small amplitude coefficients represent the incoherent component, which has near Gaussian vorticity PDF, contains no coherent structures, rapidly loses correlation in time, and does not contribute significantly to the transport properties of the flow. This suggests that one can describe and simulate such turbulent flow using a relatively small number of wavelet or wavelet packet modes.Comment: experimental work aprox 17 pages, 11 figures, accepted to appear in PRE, last few figures appear at the end. clarifications, added references, fixed typo

Old Drugs To Treat Resistant Bugs: Methicillin-Resistant Staphylococcus aureus Isolates with mecC Are Susceptible to a Combination of Penicillin and Clavulanic Acid.

β-Lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA) is mediated by the expression of an alternative penicillin-binding protein 2a (PBP2a) (encoded by mecA) with a low affinity for β-lactam antibiotics. Recently, a novel variant of mecA, known as mecC, was identified in MRSA isolates from both humans and animals. In this study, we demonstrate that mecC-encoded PBP2c does not mediate resistance to penicillin. Rather, broad-spectrum β-lactam resistance in MRSA strains carrying mecC (mecC-MRSA strains) is mediated by a combination of both PBP2c and the distinct β-lactamase encoded by the blaZ gene of strain LGA251 (blaZLGA251), which is part of mecC-encoding staphylococcal cassette chromosome mec (SCCmec) type XI. We further demonstrate that mecC-MRSA strains are susceptible to the combination of penicillin and the β-lactam inhibitor clavulanic acid in vitro and that the same combination is effective in vivo for the treatment of experimental mecC-MRSA infection in wax moth larvae. Thus, we demonstrate how the distinct biological differences between mecA- and mecC-encoded PBP2a and PBP2c have the potential to be exploited as a novel approach for the treatment of mecC-MRSA infections.This work was supported by a Medical Research Council (MRC) Partnership Grant (G1001787/1) held between the Department of Veterinary Medicine, University of Cambridge (M. A. H.), the School of Clinical Medicine, University of Cambridge (S. J. P.), the Moredun Research Institute (R. N. Z.) and the Wellcome Trust Sanger Institute (J. P. and S. J. P.).This is the author accepted manuscript. The final version is available from American Society for Microbiology via http://dx.doi.org/10.1128/AAC.01469-1

Novel mutations in penicillin-binding protein genes in clinical Staphylococcus aureus isolates that are methicillin resistant on susceptibility testing, but lack the mec gene.

OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) is an important global health problem. MRSA resistance to β-lactam antibiotics is mediated by the mecA or mecC genes, which encode an alternative penicillin-binding protein (PBP) 2a that has a low affinity to β-lactam antibiotics. Detection of mec genes or PBP2a is regarded as the gold standard for the diagnosis of MRSA. We identified four MRSA isolates that lacked mecA or mecC genes, but were still phenotypically resistant to pencillinase-resistant β-lactam antibiotics. METHODS: The four human S. aureus isolates were investigated by whole genome sequencing and a range of phenotypic assays. RESULTS: We identified a number of amino acid substitutions present in the endogenous PBPs 1, 2 and 3 that were found in the resistant isolates but were absent in closely related susceptible isolates and which may be the basis of resistance. Of particular interest are three identical amino acid substitutions in PBPs 1, 2 and 3, occurring independently in isolates from at least two separate multilocus sequence types. Two different non-conservative substitutions were also present in the same amino acid of PBP1 in two isolates from two different sequence types. CONCLUSIONS: This work suggests that phenotypically resistant MRSA could be misdiagnosed using molecular methods alone and provides evidence of alternative mechanisms for β-lactam resistance in MRSA that may need to be considered by diagnostic laboratories

Blueberry Advisory Committee Research Report

The 1984 edition of the Blueberry Progress Reports was prepared for the Maine Blueberry Commission and the University of Maine Blueberry Advisory Committee by researchers with the Maine Agricultural Experiment Station and Maine Cooperative Extension Service at the University of Maine, Orono. Projects in this report include: 1. Control, biology, and ecology of insects affecting lowbush blueberries . 2. Chemical control of mummyberry disease (Monilinia vaccinii-corymbosi) 3. New Fungicides for control of Botrytis blossom blight 4. Nutritional survey of selected lowbush blueberry fields 5. Interaction of fertility and pruning practices on soil characteristics and lowbush blueberry growth and yield 6. Long term effects of N and NPK fertilizer on plant growth and yield 7. The effect of N fertilization on clonal spread 8. Nutritional responses of the lowbush blueberry in new plantings as related to early establishment 9. The effect of several mulches on frost heaving, soil moisture, soil temperature and rhizome development 10. Effectiveness of mulches and planted lowbush blueberry seedlings for stabilizing soils and increasing plant cover 11. Effect of surface mulches on stabilizing lowbush blueberry soil in barren areas 12. Frequency of fertility application for establishment of lowbush blueberry seedlings 13. Slow release vs liquid fertilizer for establishment of lowbush blueberry seedlings 14. Comparison of rooted cuttings and tissue culture propagated lowbush blueberry plants 15. The effect of growth regulator formulations on growth and rhizome production of the lowbush blueberry 16. Unburned, mowed fields 17. Blueberry concentrate 18. Blueberry product development 19. Dehydrated blueberries 20. Low-calorie blueberry jellies 21. Hexazinone and terbacil mixture for weed control 22. Hexazinone and atrazine mixture for weed control 23. Effect of hexazinone and nitrogen or nitrogen-phosphorus fertilizer on lowbush blueberry plants 24. Hand-wiper applications of herbicides on birch, maple and willow 25. Glyphosate applied after leaf drop for bunchberry control 26. Napropamide for seedling weed control 27. PP333 plant growth regulator 28. Dichlobenil for bunchberry control 29. Effect of hexazinone on weed and blueberry populations 30. Fluazifop-butyl for grass control 31. Hand-wiping and cutting treatments for dogbane 32. Evaluation of airblast sprayer application of asulam for bracken fern control 33. Evaluation of spot treatment of woody weeds with 2,4-D in oil 34. Steam heat as a control of mummyberry diseas

Understanding cognition in older patients with cancer

Cancer and neurocognitive disorders, such as dementia and delirium, are common and serious diseases in the elderly that are accompanied by high degree of morbidity and mortality. Furthermore, evidence supports the under-diagnosis of both dementia and delirium in older adults. Complex questions exist regarding the interaction of dementia and delirium with cancer, beginning with guidelines on how best measure disease severity, the optimal screening test for either disorder, the appropriate level of intervention in the setting of abnormal findings, and strategies aimed at preventing the development or progression of either process. Ethical concerns emerge in the research setting, pertaining to the detection of cognitive dysfunction in participants, validity of consent, disclosure of abnormal results if screening is pursued, and recommended level of intervention by investigators. Furthermore, understanding the ways in which comorbid cognitive dysfunction and cancer impact both cancer and non-cancer-related outcomes is essential in guiding treatment decisions. In the following article, we will discuss what is presently known of the interactions of pre-existing cognitive impairment and delirium with cancer. We will also discuss identified deficits in our knowledge base, and propose ways in which innovative research may address these gaps

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse events (irAEs). Many of these are driven by the same immunologic mechanisms responsible for the drugs\u27 therapeutic effects, namely blockade of inhibitory mechanisms that suppress the immune system and protect body tissues from an unconstrained acute or chronic immune response. Skin, gut, endocrine, lung and musculoskeletal irAEs are relatively common, whereas cardiovascular, hematologic, renal, neurologic and ophthalmologic irAEs occur much less frequently. The majority of irAEs are mild to moderate in severity; however, serious and occasionally life-threatening irAEs are reported in the literature, and treatment-related deaths occur in up to 2% of patients, varying by ICI. Immunotherapy-related irAEs typically have a delayed onset and prolonged duration compared to adverse events from chemotherapy, and effective management depends on early recognition and prompt intervention with immune suppression and/or immunomodulatory strategies. There is an urgent need for multidisciplinary guidance reflecting broad-based perspectives on how to recognize, report and manage organ-specific toxicities until evidence-based data are available to inform clinical decision-making. The Society for Immunotherapy of Cancer (SITC) established a multidisciplinary Toxicity Management Working Group, which met for a full-day workshop to develop recommendations to standardize management of irAEs. Here we present their consensus recommendations on managing toxicities associated with immune checkpoint inhibitor therapy

Macrocyclic colibactin induces DNA double-strand breaks via copper-mediated oxidative cleavage.

Colibactin is an assumed human gut bacterial genotoxin, whose biosynthesis is linked to the clb genomic island that has a widespread distribution in pathogenic and commensal human enterobacteria. Colibactin-producing gut microbes promote colon tumour formation and enhance the progression of colorectal cancer via cellular senescence and death induced by DNA double-strand breaks (DSBs); however, the chemical basis that contributes to the pathogenesis at the molecular level has not been fully characterized. Here, we report the discovery of colibactin-645, a macrocyclic colibactin metabolite that recapitulates the previously assumed genotoxicity and cytotoxicity. Colibactin-645 shows strong DNA DSB activity in vitro and in human cell cultures via a unique copper-mediated oxidative mechanism. We also delineate a complete biosynthetic model for colibactin-645, which highlights a unique fate of the aminomalonate-building monomer in forming the C-terminal 5-hydroxy-4-oxazolecarboxylic acid moiety through the activities of both the polyketide synthase ClbO and the amidase ClbL. This work thus provides a molecular basis for colibactin's DNA DSB activity and facilitates further mechanistic study of colibactin-related colorectal cancer incidence and prevention